Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) 2 Aminobutanamide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102260721A details a green enzymatic route for Levetiracetam intermediates, offering significant cost reduction in API manufacturing and superior supply chain reliability.
Patent CN106834372B reveals a novel transaminase method for (S)-2-aminobutanamide. Achieve >99.5% ee and significant cost reduction in API manufacturing with scalable green chemistry.